ALSO NOTED: S&P to rate non-profit hospitals' IT investments; Pharmas winning legal battle over pre-emption; and much more...
> Ratings firm Standard & Poor's has announced that it plans to track not-for-profit hospitals' IT investments and factor them in significantly in how they rate the hospitals' financial health. FierceHealthFinance
> It looks like pharmaceutical companies may be winning one of their key arguments--that since they're regulated by the FDA, plaintiffs are pre-empted from suing in state courts. Let's see what the Supremes think. FiercePharma
> Think your electronic medical record system is just for patient care? Think again, say policy makers and researchers. FierceHealthIT
> Stem cell researchers who managed to engineer a human embryo are now facing criticism that their work is a big step toward designing babies. FierceBioResearcher
And Finally... What includes Harry Truman's 1948 Democratic National Convention speech, Michael Jackson's "Thriller" and Fiorello LaGuardia reading comics? Article
Comments
Post new comment
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies




